Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Abiomed, Inc.
  6. Summary
    ABMD   US0036541003

ABIOMED, INC.

(ABMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/14/2021 06/15/2021 06/16/2021 06/17/2021 06/18/2021 Date
302.87(c) 301.72(c) 303.3(c) 312.61(c) 316.96 Last
274 080 217 391 287 305 366 251 209 338 Volume
+1.23% -0.38% +0.52% +3.07% +1.39% Change
More quotes
Financials (USD)
Sales 2022 1 016 M - -
Net income 2022 197 M - -
Net cash position 2022 743 M - -
P/E ratio 2022 73,0x
Yield 2022 -
Sales 2023 1 166 M - -
Net income 2023 235 M - -
Net cash position 2023 780 M - -
P/E ratio 2023 61,4x
Yield 2023 -
Capitalization 14 160 M 14 160 M -
EV / Sales 2022 13,2x
EV / Sales 2023 11,5x
Nbr of Employees 1 725
Free-Float 92,4%
More Financials
Company
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and... 
Read more
More about the company
Ratings of Abiomed, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ABIOMED, INC.
08:09aABIOMED  : Deutsche Bank Starts Abiomed at Buy With $360 Price Target
MT
06/02INSIDER TRENDS : Abiomed Insider Tax Sale Continues 90-Day Selling Trend
MT
06/02INSIDER TRENDS : Insider at Abiomed Sale for Taxes Adds to 90-Day Selling Trend
MT
06/01ABIOMED  : Buys Medical Device Firm preCARDIA for Undisclosed Sum
MT
06/01ABIOMED  : Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve..
PU
06/01ABIOMED INC  : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
06/01ABIOMED  :  Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, t..
BU
05/25ABIOMED  : to Present at Upcoming Investor Conferences
BU
05/21ABIOMED  : Insider Selling at Abiomed (ABMD) is Significant
MT
05/21ABIOMED  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/20INSIDER TRENDS : Abiomed Insider Extends 90-Day Selling Trend
MT
05/18INSIDER TRENDS : Abiomed Insider Tax Sale Continues 90-Day Selling Trend
MT
05/18INSIDER TRENDS : Insider at Abiomed Sale for Taxes Adds to 90-Day Selling Trend
MT
04/29ABIOMED  : Reports Higher Fiscal Q4 Earnings, Revenue; Issues FY22 Outlook
MT
04/29ABIOMED : Fiscal Q4 Earnings Snapshot
AQ
More news
News in other languages on ABIOMED, INC.
06/01ABIOMED  : übernimmt preCARDIA, ein bahnbrechendes Medizintechnikunternehmen, um..
06/01ABIOMED  : rachète preCARDIA, une société d'instruments médicaux innovante, dans..
04/30ABIOMED  : Endergebnisse der NCSI (National Cardiogenic Shock Initiative) - Stud..
04/29ABIOMED  : beruft Dr. Paula A. Johnson in das Board of Directors
04/29ABIOMED  : Les résultats finaux de l'étude National Cardiogenic Shock Initiative..
More news
Analyst Recommendations on ABIOMED, INC.
More recommendations
Analysis
Big Tech drives S&P 500 to record high in coronavirus rally
Chart ABIOMED, INC.
Duration : Period :
Abiomed, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABIOMED, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 371,67 $
Last Close Price 312,61 $
Spread / Highest target 36,0%
Spread / Average Target 18,9%
Spread / Lowest Target -21,6%
EPS Revisions
Managers and Directors
NameTitle
Michael R. Minogue Chairman, President & Chief Executive Officer
Todd A. Trapp Chief Financial Officer & Vice President
Thorsten Sieß Chief Technology Officer & Vice President
Charles A. Simonton Chief Medical Officer
Laxmi N. Peri Vice President-Engineering
Sector and Competitors
1st jan.Capitalization (M$)
ABIOMED, INC.-6.45%14 160
THERMO FISHER SCIENTIFIC4.36%191 043
DANAHER CORPORATION15.73%183 370
INTUITIVE SURGICAL, INC.8.18%104 797
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.7.18%86 082
SIEMENS HEALTHINEERS AG19.08%66 948